With the analysis among 7,392 patents, we discovered top 444 key players by total patent application. Arrowhead Pharmaceuticals, Inc., Genentech, Inc., Immatics Biotechnologies GmbH are dominant in this area. They take 6.79% of the total patent filing.
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 283
California, United States
Patent: 114
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 105
The General Hospital Corp.
Massachusetts, United States
Patent: 98
F. Hoffmann-La Roche Ltd.
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 90
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 71
Baden-Württemberg, Germany
Patent: 51
Hiroshima-ken, Japan
Patent: 50
Institut National de la Santé et de la Recherche Médicale
With the analysis among 345 patents, we discovered top 36 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, HepaRegeniX GmbH, Espervita Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Baden-Württemberg, Germany
Patent: 51
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Oost-Vlaanderen, Belgium
Patent: 9
Seaport Diagnostics, Inc.
Massachusetts, United States
Patent: 7
Martin Pharmaceuticals, Inc.
New York, United States
Patent: 7
California, United States
Patent: 7
With the analysis among related 3,958 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Arrowhead Pharmaceuticals, Inc., Dicerna Pharmaceuticals, Inc., Institut National de la Santé et de la Recherche Médicale take 8.14% of patent filing during this period.
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 186
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 71
Institut National de la Santé et de la Recherche Médicale
Baden-Württemberg, Germany
Patent: 51
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 45
Regents of the University of California
California, United States
Patent: 38
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 35
Zhejiang Sheng, China
Patent: 34
Hubei Sheng, China
Patent: 28
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 27
With the analysis among related 3,958 patents in last 5 years, we discover 218 new entrants. Dicerna Pharmaceuticals, Inc., HepaRegeniX GmbH, Bioverativ Therapeutics, Inc. are the most active new entrants in this area.
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 71
Baden-Württemberg, Germany
Patent: 51
Bioverativ Therapeutics, Inc.
Massachusetts, United States
Patent: 22
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 21
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Hefei Zhongkepu Ruisheng Biomedical Technology Co., Ltd.
Anhui Sheng, China
Patent: 20
Aligos Therapeutics, Inc.
California, United States
Patent: 19
Chong Kun Dang Pharmaceutical Corp.
Suzhou AlphaMa Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 11
With the analysis among 4,355 patents, we discovered top 265 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Zhejiang University, Massachusetts Institute of Technology are dominant in this area. They take 10.38% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 187
Zhejiang Sheng, China
Patent: 104
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 84
University of Connecticut
Connecticut, United States
Patent: 50
Hubei Sheng, China
Patent: 43
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 41
Tokyo-to, Japan
Patent: 38
Université de Paris 5 René Descartes
The Scripps Research Institute
California, United States
Patent: 36
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 34